Romark, L.C. is a pharmaceutical company committed to the discovery, development and commercialization of innovative small molecules for treating infectious diseases and cancers. Our people share a passion for scientific discovery and a desire to make a difference in the world's health. Throughout all phases of drug discovery and development, we are teamed in a quest to provide new treatments for diseases that impact the lives of people worldwide
The Company uses a proprietary technology platform to discover small molecules targeting cell signaling pathways. This research has led to the discovery of a new class of drugs called the thiazolides. The first thiazolide, nitazoxanide, is already commercialized in the United States. Other new compounds and uses are being developed as part of several collaborative research programs.
Romark Address
3000 Bayport Drive, Suite 200 Tampa, FL United States